Tags

Type your tag names separated by a space and hit enter

Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.
East Mediterr Health J. 2013 Apr; 19(4):389-92.EM

Abstract

The Islamic Hajj to Makkah (Mecca) has been associated with outbreaks of invasive meningococcal disease and the global spread of Neisseria meningitidis serogroup W-135. For Hajj pilgrims the quadrivalent vaccination against serogroups A, C, W-135 and Y is a mandatory requirement. Novel conjugate vaccines may provide benefits for the community by reduction of carriage. With the introduction of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo, Menactra, and others pending license) and their recent implementation in Saudi Arabia, experts from 11 countries in the Middle East region met at a Meningococcal Leadership Forum (MLF), in Dubai in May 2010 to exchange opinions on meningococcal disease and prevention strategies. These experts discussed the importance of introducing conjugate vaccines for pilgrims and travellers, and elaborated a consensus recommendation to support healthcare professionals and decision-makers.

Authors+Show Affiliations

Department of Microbiology, King Saud University, Riyadh, Saudi Arabia. amshibl@ksu.edu.saNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23882966

Citation

Shibl, A, et al. "Consensus Recommendation for Meningococcal Disease Prevention for Hajj and Umra Pilgrimage/travel Medicine." Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = al-Majallah Al-sihhiyah Li-sharq Al-mutawassit, vol. 19, no. 4, 2013, pp. 389-92.
Shibl A, Tufenkeji H, Khalil M, et al. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. East Mediterr Health J. 2013;19(4):389-92.
Shibl, A., Tufenkeji, H., Khalil, M., & Memish, Z. (2013). Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = al-Majallah Al-sihhiyah Li-sharq Al-mutawassit, 19(4), 389-92.
Shibl A, et al. Consensus Recommendation for Meningococcal Disease Prevention for Hajj and Umra Pilgrimage/travel Medicine. East Mediterr Health J. 2013;19(4):389-92. PubMed PMID: 23882966.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. AU - Shibl,A, AU - Tufenkeji,H, AU - Khalil,M, AU - Memish,Z, AU - ,, PY - 2013/7/26/entrez PY - 2013/7/26/pubmed PY - 2013/8/14/medline SP - 389 EP - 92 JF - Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit JO - East. Mediterr. Health J. VL - 19 IS - 4 N2 - The Islamic Hajj to Makkah (Mecca) has been associated with outbreaks of invasive meningococcal disease and the global spread of Neisseria meningitidis serogroup W-135. For Hajj pilgrims the quadrivalent vaccination against serogroups A, C, W-135 and Y is a mandatory requirement. Novel conjugate vaccines may provide benefits for the community by reduction of carriage. With the introduction of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo, Menactra, and others pending license) and their recent implementation in Saudi Arabia, experts from 11 countries in the Middle East region met at a Meningococcal Leadership Forum (MLF), in Dubai in May 2010 to exchange opinions on meningococcal disease and prevention strategies. These experts discussed the importance of introducing conjugate vaccines for pilgrims and travellers, and elaborated a consensus recommendation to support healthcare professionals and decision-makers. SN - 1020-3397 UR - https://www.unboundmedicine.com/medline/citation/23882966/full_citation L2 - http://applications.emro.who.int/emhj/v19/04/EMHJ_2013_19_4_389_392.pdf DB - PRIME DP - Unbound Medicine ER -